Stocks › RVNC

RVNC

RVNC·USD
$3.65
+0.00 (+0.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
RVNC
RVNC
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RVNCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of RVNC by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Thomas R CarperThomas R CarperSenate · D · DE RVNCRVNC · Stock Purchase
$1,001 - $15,000
Nov 2, 2023 Oct 4, 2023 Filing ↗

Whale Activity

Institutional 13F positions

No 13F positions in RVNC among the institutional filers we track.

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by RVNC insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

543 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Gangolli Julian SDirector Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Foley Mark JPresident & CEO · Director Disposition to issuer −84.7K — — Feb 6, 2025 Form 4 ↗
Foley Mark JPresident & CEO · Director Grant / award +84.7K $0.00 $0 Feb 6, 2025 Form 4 ↗
Foley Mark JPresident & CEO · Director Disposition to issuer −27.9K — — Feb 6, 2025 Form 4 ↗
Schilke TobinCFO Disposition to issuer −20.9K — — Feb 6, 2025 Form 4 ↗
Schilke TobinCFO Grant / award +20.9K $0.00 $0 Feb 6, 2025 Form 4 ↗
Schilke TobinCFO Disposition to issuer −103.6K — — Feb 6, 2025 Form 4 ↗
Moxie DwightCLO & GC Disposition to issuer −18.1K — — Feb 6, 2025 Form 4 ↗
Moxie DwightCLO & GC Grant / award +18.1K $0.00 $0 Feb 6, 2025 Form 4 ↗
Moxie DwightCLO & GC Disposition to issuer −96.0K — — Feb 6, 2025 Form 4 ↗
Hollander DavidCMO & Global Therapeutics Lead Disposition to issuer −95.2K — — Feb 6, 2025 Form 4 ↗
Jordan EricaChief Commercial Officer Disposition to issuer −107.9K — — Feb 6, 2025 Form 4 ↗
Ware Olivia CDirector Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Kolaja Carey OConnorDirector Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Coric VladDirector Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Beraud JillDirector Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Nolet ChrisDirector Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Russell Angus C.Director Disposition to issuer −15.0K — — Feb 6, 2025 Form 4 ↗
Gangolli Julian SDirector Tender of shares −30.1K $3.65 $110K Feb 4, 2025 Form 4 ↗
Foley Mark JPresident & CEO · Director Tender of shares −110.9K $3.65 $405K Feb 4, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding RVNC · SEC Form N-PORT

Funds report their holdings by CUSIP, and RVNC could not be matched to one, so no fund holdings are shown.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming RVNC as client

No lobbying filings found naming RVNC as the client.

Government Contracts

Federal awards to RVNC · USAspending

No federal contract awards found for RVNC.

U.S. Patents

Recent USPTO applications naming RVNC

No USPTO patent applications found for RVNC.

Annual Financials

From RVNC's 10-K filings · XBRL

No annual XBRL figures on record for RVNC. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history

No stock splits in RVNC's price history.

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About RVNC

From SEC EDGAR company records

No company profile on record.